Assessing quality of diabetes care by measuring longitudinal changes in hemoglobin A1c in the Veterans Health Administration.

CONTEXT A1c levels are widely used to assess quality of diabetes care provided by health care systems. Currently, cross-sectional measures are commonly used for such assessments. OBJECTIVE To study within-patient longitudinal changes in A1c levels at Veterans Health Administration (VHA) facilities as an alternative to cross-sectional measures of quality of diabetes care. DESIGN Longitudinal study using institutional data on individual patient A1c level over time (October 1, 1998-September 30, 2000) with time variant and invariant covariates. SETTING One hundred and twenty-five VHA facilities nationwide, October 1, 1998-September 30, 2000. PATIENTS Diabetic veteran users with A1c measurement performed using National Glycosylated Hemoglobin Standardization Project certified A1c lab assay methods. EXPOSURES Characteristics unlikely to reflect quality of care, but known to influence A1c levels, demographics, and baseline illness severity. MAIN OUTCOME MEASURE Monthly change in A1c for average patient cared for at each facility. RESULTS The preponderance of facilities showed monthly declines in within-patient A1c over the study period (mean change of -0.0148 A1c units per month, range -0.074 to 0.042). Individual facilities varied in their monthly change, with 105 facilities showing monthly declines (70 significant at .05 level) and 20 showing monthly increases (5 significant at .05 level). Case-mix adjustment resulted in modest changes (mean change of -0.0131 case-mix adjusted A1c units per month, range -0.079 to 0.043). Facilities were ranked from worst to best, with attached 90 percent confidence intervals. Among the bottom 10 ranked facilities, four remained within the bottom decile with 90 percent confidence. CONCLUSIONS There is substantial variation in facility-level longitudinal changes in A1c levels. We propose that evaluation of change in A1c levels over time can be used as a new measure to reflect quality of care provided to populations of individuals with chronic disease.

[1]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[2]  M. Weiner,et al.  Cross-Sectional versus Longitudinal Performance Assessments in the Management of Diabetes , 2004, Medical care.

[3]  K. Shima,et al.  Kinetics of HbA1c, Glycated Albumin, and Fructosamine and Analysis of Their Weight Functions Against Preceding Plasma Glucose Level , 1995, Diabetes Care.

[4]  A. Jha,et al.  Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. , 2003, The New England journal of medicine.

[5]  M. Safford,et al.  Disparities in use of lipid-lowering medications among people with type 2 diabetes mellitus. , 2003, Archives of internal medicine.

[6]  Rodney A Hayward,et al.  Comparing clinical automated, medical record, and hybrid data sources for diabetes quality measures. , 2002, The Joint Commission journal on quality improvement.

[7]  P. Diggle.  Analysis of Longitudinal Data , 1995 .

[8]  D. Berlowitz,et al.  Problems in Assessing Diabetes Control in an Ambulatory Setting , 1998, American journal of medical quality : the official journal of the American College of Medical Quality.

[9]  M. Safford,et al.  Performance status of health care facilities changes with risk adjustment of HbA1c. , 2000, Diabetes care.

[10]  G L Myers,et al.  The national glycohemoglobin standardization program: a five-year progress report. , 2001, Clinical chemistry.

[11]  B. Yawn,et al.  Identifying Persons with Diabetes Using Medicare Claims Data , 1999, American journal of medical quality : the official journal of the American College of Medical Quality.

[12]  D. Spiegelhalter,et al.  Reliability of league tables of in vitro fertilisation clinics: retrospective analysis of live birth rates. , 1998, BMJ.

[13]  M. Chin,et al.  Quality of diabetes care in community health centers. , 2000, American journal of public health.

[14]  Rury R Holman,et al.  Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). , 2002, Diabetes care.

[15]  J. Hsu.  Multiple Comparisons: Theory and Methods , 1996 .

[16]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[17]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[18]  R. Bosker.  Boekbespreking van "A.S. Bryk & S.W. Raudenbusch - Hierarchical linear models: Applications and data analysis methods" : Sage Publications, Newbury Parki, London/New Delhi 1992 , 1995 .

[19]  Harvey Goldstein,et al.  League Tables and Their Limitations: Statistical Issues in Comparisons of Institutional Performance , 1996 .

[20]  A M Epstein,et al.  Influence of cardiac-surgery performance reports on referral practices and access to care. A survey of cardiovascular specialists. , 1996, The New England journal of medicine.

[21]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[22]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[23]  K. Flegal,et al.  Racial and ethnic differences in glycemic control of adults with type 2 diabetes. , 1999, Diabetes care.